Holley And 2 Other Stocks Under $5 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders are buying shares of Harvard Bioscience, Sypris Solutions, and Holley, indicating confidence in these companies. Notable transactions include purchases by executives and directors, with Harvard Bioscience facing weaker-than-expected sales, Sypris Solutions appointing a new VP, and Holley receiving an Outperform rating from Telsey Advisory Group.
June 17, 2024 | 11:51 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Harvard Bioscience CEO James W Green bought 10,000 shares at $2.91 each, despite weaker-than-expected quarterly sales reported on May 7.
The insider purchase by the CEO suggests confidence in the company's future prospects, which could positively impact the stock price in the short term despite recent weaker sales.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Holley Exec. Chairman Matthew E Rubel bought 14,493 shares at $3.39 each. Telsey Advisory Group maintained an Outperform rating with a $6.5 price target.
The insider purchase and the maintained Outperform rating with a high price target indicate strong confidence in the company's future, likely leading to a short-term price increase.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sypris Solutions Director Gary L Convis acquired 20,000 shares at $1.92 each. The company recently appointed Michael D. Sedgwick as VP and General Manager of Sypris Electronics.
The insider purchase and the appointment of a new VP suggest positive internal developments, which could lead to a short-term increase in the stock price.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70